Wells Fargo & Company Cuts Omega Healthcare Investors (NYSE:OHI) Price Target to $41.00

Omega Healthcare Investors (NYSE:OHIFree Report) had its price target reduced by Wells Fargo & Company from $43.00 to $41.00 in a research report sent to investors on Monday morning,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the real estate investment trust’s stock.

Several other analysts also recently issued reports on OHI. BMO Capital Markets raised Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 price target on the stock in a report on Monday, December 9th. Mizuho raised their price target on Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a “neutral” rating in a report on Thursday, December 5th. Royal Bank of Canada raised their price target on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a report on Monday, November 11th. Finally, JMP Securities reissued a “market perform” rating on shares of Omega Healthcare Investors in a report on Friday, February 7th. Five investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $41.44.

Read Our Latest Stock Report on OHI

Omega Healthcare Investors Price Performance

Shares of OHI opened at $36.58 on Monday. The firm has a market cap of $10.31 billion, a price-to-earnings ratio of 23.60, a PEG ratio of 1.09 and a beta of 1.00. The stock has a 50 day moving average of $37.07 and a 200-day moving average of $38.97. The company has a current ratio of 7.07, a quick ratio of 7.07 and a debt-to-equity ratio of 1.02. Omega Healthcare Investors has a 52 week low of $29.66 and a 52 week high of $44.42.

Omega Healthcare Investors (NYSE:OHIGet Free Report) last issued its earnings results on Wednesday, February 5th. The real estate investment trust reported $0.74 EPS for the quarter, topping the consensus estimate of $0.41 by $0.33. Omega Healthcare Investors had a return on equity of 9.71% and a net margin of 38.65%. As a group, analysts forecast that Omega Healthcare Investors will post 2.86 EPS for the current year.

Omega Healthcare Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, February 18th. Stockholders of record on Monday, February 10th were issued a $0.67 dividend. The ex-dividend date of this dividend was Monday, February 10th. This represents a $2.68 annualized dividend and a dividend yield of 7.33%. Omega Healthcare Investors’s dividend payout ratio (DPR) is 172.90%.

Institutional Trading of Omega Healthcare Investors

Several institutional investors have recently modified their holdings of OHI. Venturi Wealth Management LLC increased its position in Omega Healthcare Investors by 29.4% in the 3rd quarter. Venturi Wealth Management LLC now owns 1,259 shares of the real estate investment trust’s stock worth $51,000 after purchasing an additional 286 shares during the last quarter. Johnson Investment Counsel Inc. increased its position in Omega Healthcare Investors by 2.3% in the 4th quarter. Johnson Investment Counsel Inc. now owns 13,147 shares of the real estate investment trust’s stock worth $498,000 after purchasing an additional 295 shares during the last quarter. Bessemer Group Inc. increased its position in Omega Healthcare Investors by 5.9% in the 4th quarter. Bessemer Group Inc. now owns 5,443 shares of the real estate investment trust’s stock worth $207,000 after purchasing an additional 303 shares during the last quarter. US Bancorp DE increased its position in Omega Healthcare Investors by 1.9% in the 4th quarter. US Bancorp DE now owns 16,173 shares of the real estate investment trust’s stock worth $612,000 after purchasing an additional 309 shares during the last quarter. Finally, Samalin Investment Counsel LLC increased its position in Omega Healthcare Investors by 1.5% in the 4th quarter. Samalin Investment Counsel LLC now owns 21,582 shares of the real estate investment trust’s stock worth $817,000 after purchasing an additional 314 shares during the last quarter. Institutional investors and hedge funds own 65.25% of the company’s stock.

Omega Healthcare Investors Company Profile

(Get Free Report)

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

See Also

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.